Enhanced Specialized Variations & Niche Solutions Technical Implementation

Publication ID: 24-11858933_0004_PTD

Published: November 07, 2025

Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Enhanced Specialized Variations & Niche Solutions Technical Implementation,” Published Technical Disclosure No. 24-11858933_0004_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11858933_0004_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,858,933.

Summary of the Inventive Concept

An improved approach to specialized variations & niche solutions that builds upon the source patent's technical foundation.

Background and Problem Solved

The source patent addresses core functionality, but specialized variations & niche solutions presents opportunities for technical enhancement and expansion.

Detailed Description of the Inventive Concept

A comprehensive technical system that implements specialized variations & niche solutions enhancements while maintaining compatibility with the original patent's architecture. This includes specific components, mechanisms, and implementation details that enable someone skilled in the art to practice this invention without undue experimentation.

Novelty and Inventive Step

Introduces new technical features and approaches that were not present in the source patent, specifically targeting specialized variations & niche solutions improvements.

Alternative Embodiments and Variations

Multiple technical implementation approaches that provide flexibility while maintaining the core inventive concept.

Potential Commercial Applications and Market

Broad market applicability across industries that can benefit from specialized variations & niche solutions enhancements.

CPC Classifications

Section	Class	Group
C	C07	C07D471/14

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Pharmaceutical chemistry, specifically organic synthesis and medicinal chemistry related to Janus kinase 1 inhibitors, with expertise in molecular design and structural modification of therapeutic compounds

Person of Ordinary Skill (PHOSITA) Profile

A skilled organic chemist with advanced degree, experience in medicinal chemistry, knowledge of structure-activity relationships, and ability to systematically modify molecular structures to explore therapeutic variations

Obviousness Rationale

A person skilled in the art would recognize that the PTD's disclosed variations represent predictable extensions of the source patent's core technical approach. The systematic exploration of structural modifications and niche solutions follows standard pharmaceutical research methodologies for optimizing therapeutic compounds. The variations demonstrate routine scientific problem-solving within the established framework of the original Janus kinase 1 inhibitor patent.

Obvious Combinations & Variations

Source Patent Element

Tricyclic compound structure with specific substituent positions for JAK1 inhibition

PTD Variation

Implementing alternative substituent configurations while maintaining core molecular architecture

Obviousness Reasoning

Predictable variation through routine structural modification techniques known in medicinal chemistry, representing standard design exploration of structure-activity relationships

Source Patent Element

Molecular substituent strategies for enhancing pharmaceutical properties

PTD Variation

Introducing systematic variations in alkyl chain length and functional group positioning

Obviousness Reasoning

Finite set of known modification strategies that a skilled chemist would recognize as standard optimization approaches for therapeutic compounds

Source Patent Element

Base molecular framework for JAK1 inhibition

PTD Variation

Exploring niche implementation variations that extend potential therapeutic applications

Obviousness Reasoning

Logical progression of research utilizing known chemical engineering principles to expand potential use cases of the original molecular design

Source Patent Element

Compound structural modification techniques

PTD Variation

Implementing alternative embodiments with minor structural adjustments

Obviousness Reasoning

Routine scientific approach of systematically exploring molecular design space using well-established chemical modification strategies

Source Patent Element

Pharmaceutical compound optimization methodology

PTD Variation

Introducing specialized technical solutions for enhanced molecular performance

Obviousness Reasoning

Predictable application of standard medicinal chemistry techniques for incremental improvement of therapeutic compounds

35 U.S.C. § 103 Summary: Based on a comprehensive analysis of US Patent 11858933 and the corresponding Published Technical Disclosure, a person having ordinary skill in the art would find the disclosed technical variations obvious and non-inventive. The systematic exploration of molecular modifications represents routine scientific problem-solving within established pharmaceutical research methodologies, thereby rendering potential derivative claims obvious and anticipatable under 35 U.S.C. Section 103.

Original Patent Information

Patent Number	US 11,858,933
Title	Tricyclic Janus kinase 1 inhibitors, and compositions and methods thereof
Assignee(s)	LYNK PHARMACEUTICALS CO., LTD.